IVC Window Agreement Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGazi University

About this trial

Ultrasonographic evaluation of the inferior vena cava (IVC) is widely used in emergency and critical care settings for noninvasive assessment of intravascular volume status. The subcostal (SC) window is the standard approach; however, it is frequently limited by obesity, bowel distension, or postoperative anatomical changes. In such cases, the right coronal (RC) and anterior transhepatic (aTH) windows have been proposed as alternatives.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients (≥18 years) requiring ultrasonographic assessment of intravascular volume status will be consecutively enrolled.

Disqualifiers

Pregnancy, refusal to participate, and inability to obtain any IVC image via the SC approach.

Trial population

Adult patients (≥18 years) requiring ultrasonographic assessment of intravascular volume status in the emergency departments, intensive care units, and other acute care settings.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

900 Participants
are grouped into 1 trial group
Group A: Patients who need volume status assessment

Trial outcomes

Primary outcomes

1

The intermethod agreement of IVC diameter and collapsibility index measurements

The intermethod agreement of IVC diameter and collapsibility index measurements obtained from the subcostal (SC), anterior transhepatic (aTH), and right coronal (RC) ultrasonographic windows under a standardized imaging protocol, and to determine whether aTH and RC windows can serve as reliable alternatives to the SC approach across diverse clinical settings and operator profiles.

Time frame
90 days

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: